Columbia native Rachel Thompson got the opportunity to meet Billie Jean King at the U.S. Open last week while accepting the national Novo Nordisk Donnelly Scholarship.

BENGALURU] European shares finished marginally higher on Monday (Sep 1), supported by defence stocks, while Novo Nordisk ...

Dow Jones Top Company Headlines at 5 PM ET: Companies Reap Cash Savings From Trump's New Tax Law | Aldi ... Benefits ripple through the oil, technology and telecommunications industries. The German ...

European shares edged up on Monday, led by a rally in defence stocks, as Novo Nordisk's weight-loss drug showed strong results. However, gains were limited due to concerns about global debt and U.S.

People with obesity and cardiovascular disease saw a 57% greater reduction in their risk when taking Wegovy versus rival weight loss drugs, per a new study.

European shares finished marginally higher on Monday, supported by defence stocks, while Novo Nordisk gained after data ...

Novo Nordisk stock rises after a new study showed Wegovy resulted in reduced risk of heart attack, stroke or death compared with rival Eli Lilly’s weight-loss drug Zepbound.

The study used evidence gathered from patient experiences rather than a controlled trial, Novo said.

Conventional wisdom says GLP-1 drugs must be taken indefinitely to maintain weight loss. But some researchers, payers and ...

Wegovy may help people with heart disease more than Zepbound A new study reveals the obesity drug Wegovy, from maker Novo Nordisk, may help protect the heart more than competing drug Zepbound from Eli ...

Novo Nordisk A/S (NYSE:NVO) is a discover, developer, and marketer of pharmaceutical products, particularly for diabetes care.